Intraperitoneal chemotherapy for ovarian cancer
We use this type of ovarian cancer chemotherapy to directly target the ovaries and abdominal area with a higher concentration of chemotherapy drugs, while limiting the amount that reaches the rest of the body. This allows the chemotherapy to “bathe” the abdomen for a longer period of time and treats microscopic disease throughout the abdomen.
What is intraperitoneal chemotherapy?
Intraperitoneal chemotherapy is another innovative ovarian cancer treatment available at Cancer Treatment Centers of America® (CTCA). Intraperitoneal chemotherapy delivers chemotherapy drugs directly to the abdominal cavity.
During the treatment, chemotherapy drugs are injected through a catheter, which is implanted during debulking surgery. Most women receive intravenous chemotherapy at the same time as intraperitoneal chemotherapy. We typically treat patients every three weeks for a total of six ovarian cancer chemotherapy treatments.